Q4 2017 Annual Press Conference, and Analysts Call

Our Q4/FY 2017 results have been published on March 8, 2018.

Type of Event

Conference Call

08 Mar 2018

From 07:00 to 15:00

We achieve targets for 2017 – dividend to increase

  • Healthcare and Life Science drive sales growth (+2.0%)
  • EBITDA pre (–1.7%) burdened by currency headwinds
  • Organic sales growth in all regions
  • Progress made in reducing net financial debt
  • Dividend proposal € 1.25 (+€ 0.05)

We are staying the course

“2017 was a good year for our company. We performed well in a challenging environment and met all ourtargets for  the year. We are staying the course and will continue to purposefully implement our innovation-driven growth strategies for Healthcare, Life Science and Performance Materials. In addition, we are resolutely working to quickly lower our acquisition-related debt-to-equity ratio.”

(Stefan Oschmann, CEO and Chairman of the Executive Board)

Related News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Achieves Targets for 2017 – Dividend to Increase

    Merck KGaA, Darmstadt, Germany met its targets for 2017 and achieved important strategic successes with the approvals of two new medicines.


Markus Talanow

Financial Communications

Constantin Fest

Head of Investor Relations


You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement